Interplay among cardiotrophin-1, prostaglandins, and vascular endothelial growth factor in rat liver regeneration

Authors

  • Naiara Beraza,

    1. Division of Hepatology and Gene Therapy, CIMA (Center for Applied Medical Research), University of Navarra, Pamplona, Spain
    Search for more papers by this author
  • Juan Martín Marqués,

    1. Division of Hepatology and Gene Therapy, CIMA (Center for Applied Medical Research), University of Navarra, Pamplona, Spain
    Search for more papers by this author
  • Eduardo Martínez-Ansó,

    1. Division of Hepatology and Gene Therapy, CIMA (Center for Applied Medical Research), University of Navarra, Pamplona, Spain
    Search for more papers by this author
  • María Iñiguez,

    1. Division of Hepatology and Gene Therapy, CIMA (Center for Applied Medical Research), University of Navarra, Pamplona, Spain
    Search for more papers by this author
  • Jesús Prieto,

    1. Division of Hepatology and Gene Therapy, CIMA (Center for Applied Medical Research), University of Navarra, Pamplona, Spain
    Search for more papers by this author
  • Matilde Bustos

    Corresponding author
    1. Division of Hepatology and Gene Therapy, CIMA (Center for Applied Medical Research), University of Navarra, Pamplona, Spain
    • Division of Hepatology and Gene Therapy, CIMA (Center for Applied Medical Research), 31008 Pamplona, Spain
    Search for more papers by this author
    • fax: (34) 948-19-47-17.


  • Conflict of interest: Nothing to report.

Abstract

Prostaglandins are hepatoprotective molecules generated in liver regeneration by the rapid induction of cyclooxygenase-2 (COX-2). Cardiotrophin-1 (CT-1) and vascular endothelial growth factor (VEGF) are other hepatoprotective mediators upregulated at 24 hours after partial hepatectomy. The interactions among these molecules during liver regeneration have not yet been defined. Here we show that rats subjected to partial hepatectomy treated with NS-398, a specific COX-2 inhibitor, exhibited cell cycle arrest, increased hepatocyte apoptosis, persistent extracellular signal-regulated kinase (ERK) 1/2 activation, and increased interleukin-6 production. These changes were associated with downregulation of CT-1 and COX-1 and altered pattern of VEGF expression. Administration of an adenovirus encoding CT-1 to NS-398-treated rats restituted normal levels of COX-1, prostaglandins, and VEGF in the liver after partial hepatectomy and restored normal liver regeneration. Furthermore, the stimulation of isolated rat hepatocytes with CT-1 increased COX-1, COX-2, and VEGF messenger RNAs and prostaglandin synthesis. Conversely, the addition of prostaglandin E1 to the culture increased CT-1 and VEGF production. In conclusion, COX-2 activation and production of prostaglandins soon after partial hepatectomy are essential requirements for hepatocyte proliferation and for the correct induction of both CT-1 and VEGF. CT-1 can restore liver regeneration after COX-2 inhibition by increasing VEGF, COX-1 expression, and prostaglandin synthesis. (HEPATOLOGY 2005;41:460–469.)

Ancillary